Ceftolozane and tazobactam for the treatment of bacterial infections a review of clinical effectiveness, cost-effectiveness, and guidelines
As antimicrobial resistance continues to be an issue across health care settings, guidelines for appropriate practices related to antibiotic prescribing and use are required. The prevalence of resistant pathogens has also encouraged the development of new treatment options to effectively combat them...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2016, 03 November 2016
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references